文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Organoid Cultures Derived from Patients with Advanced Prostate Cancer
侵权投诉

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

NormalizedRLU

A

NormalizedTumorVolume

MSK-PCa1MSK-PCa2MSK-PCa3MSK-PCa4MSK-PCa5MSK-PCa6

D

MSK-PCa1

Figure6.SensitivitytoARandPI3KInhibitorinOrganoidLinesInVitroandInVivo

(A–C)Dose-responsecurvesoforganoidlinestoenzalutamide,everolimus,andBKM120.Growthwasmeasuredinquadrupletandviabilitywasas-sayed4daysaftertreatmentattheindicateddrugconcentrations(mean±SD).

(D–E)GrowthofMSK-PCA1andMSK-PCA2xe-nografts.Treatmentwasstartedwithtumorsreachanaveragesizeof400mm3.Eachtumorwasnormalizedtothepretreatmentsize.(n=10,mean±SEM).pvaluederivedfromunpairedtwo-tailedttestofnormalizedtumorsizeattheendoftreatment.Ev:everolimus,Enz:enzalutamide,Cast:castration.

1

Enzalutamide(nM)

101001000

MSK-PCa1MSK-PCa2MSK-PCa3MSK-PCa4MSK-PCa5MSK-PCa6

NormalizedRLU

B

Time(weeks)

E

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

NormalizedTumorVolume

0.01

MSK-PCa2

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Everolimus(nM)

0.1110100

(18bone,9lymphnode,2liver,1brain,1bladder,and1pleuraleffusion)and17bloodfrompatientswithhighCTCcount>100cellsper10mlofblood.

PleaseseeExtendedExperimentalProceduresfor

clinicaldetailsofthesevenorganoidlines.Allpatientsprovidedinformedconsentandsam-pleswereprocuredandthestudywasconducted0.010.1110Time(weeks)underMemorialSloan-KetteringCancerCenter

BKM120(µM)InstitutionalReviewBoardapproval(MSKCCIRB

90-040or06-107)priortotissueacquisition.Clin-icalandpathologicdatawereenteredandmain-practiceshouldincreasetheopportunitytogeneratemoreorga-tainedinadatabasebyourresearchprojectcoordinatorwhogeneratedanoidlinesandmayallowcharacterizationoftumorgenomesseparateanonymizeddatabaseforinvestigators.Metastaticprostatecancerfrombiopsymaterialwithtoofewtumorcellsfordirectanalysisbiopsypiecesweremincedanddigestedin5mlof5mg/mlcollagenase

typeII(Invitrogen)inAdvancedDMEM/F12(ADMEM/F12)anddigestedfor

(e.g.,MSK-PCa1,MSK-PCa2,andCTCsampleMSK-PCa5).

0.5–2hrat37 Cwithgentlyshaking.Dissociatedcellswerewashedand

Underselectionpressurefromtreatment,CRPCisahighlyseededingrowthfactorreducedMatrigel(BDbiosciences).heterogeneousdisease.ThewidespreaduseofincreasinglyForisolationofCTC,8mlofbloodsampleswasdrawnintoaheparintubeat

MemorialSloan-KetteringCancerCenter.Bloodwasincubatedwith400mlmoreef caciousARpathwayinhibitorsmayfurthergenerate

multiplediscrepantresistancemechanisms.CRPCtumorcellsRosetteSepHumanCD45DepletionCocktail(StemCellTechnologies)formayremaindependentonARorAR-likeactivity,ortheymay20minatroomtemperature,thendepletedoftheredbloodcellandwhite

bloodcellusingFicoll-Paque(GE).Isolatedcirculatingtumorcellswere

dedifferentiateintoAR-independentcells(Aroraetal.,2013;Bal-washedandseededingrowthfactorreducedMatrigel(BD

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

biosciences).

basetal.,2013;Beltranetal.,2011;Carveretal.,2011;ChenHumanprostatecancerorganoidswerepassagedeitherviatriturationwithaetal.,2013).TheCRPCorganoidlinesdescribedherealreadyglassPasteurpipetordissociationwithTrypLE(Sigma-Aldrich)for5minatdisplayabroadspectrumofARlevelsaswellasARtranscrip-37 C.Passagewasperformedweeklywitha1:3ratio.

NormalizedRLU

C

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

MSK-PCa1MSK-PCa2MSK-PCa3MSK-PCa4MSK-PCa5MSK-PCa6

tionalactivity.Thegenerationofmorelineswithde nedtreat-menthistoriesshouldaccelerateourmechanisticunderstandingofmoleculardeterminantsofsensitivity.

Prostatecancersharborseveraldisease-speci cmutations,includingETS-translocations,SPOPmutations,FOXA1muta-tions,andCHD1loss.Wehavegeneratedmodelsofeachoftheseprostate-speci calterationsandanticipatethatmorewillbegeneratedinthenearfuture.Additionally,CRPCorganoidsprovideanopportunitytode negeneticlesionsthatmediateprogressiontometastaticCRPC.ThehighfrequencyofRBandTP53pathwaydysfunctionintheCRPCorganoidlinessug-geststhatdrugstargetingthesepathwaysshouldbecomeatherapeuticpriority.

EXPERIMENTALPROCEDURES

IsolationandCultureofMetastaticProstateCancerCellsandCirculatingTumorCells

BetweenDecember2012toNovember2013,wecollected32metastasissam-pleswithdocumentedtumorcontent>10%ofthecellsonpathologyreview

RNA-SequencingandAnalysis

RNAwasisolatedfromorganoidswithlowpassagenumber(lessthan5)usingQIAGENRNeasykits.LibrarypreparationandRNAsequencingwasper-formedbyMSKCCGenomicsCoreLaboratoryusingIlluminaHiSeqwith50or75bppaired-endreads,and 30millionreadsweregeneratedforeachsample.Thereadsweremappedhumangenomereferencesequence(GRC37/hg19)usingSTAR(ver2.3)(Dobinetal.,2013)andquanti edintoRPKMusingCuf inkswithupperquartilenormalization(ver2.1)(Robertsetal.,2011).HeatmapsandclusteringanalysisusingPearsonCorrelationweregeneratedusingGENE-E(doc.guandang.net).RepresentativeregionsaredisplayedusingIntegratedGenomicsViewer(IGV,doc.guandang.net).

DNAExtraction,QualityControlLibraryPreparation

DNAfromtheseventumororganoidsampleswasextractedusingNucleospintissueXS(Clontech)accordingtomanufacturersprotocolforculturedcells.ThebuffycoatDNAofthecasesexceptMSK-PCa2wasextractedusingNu-cleospintissueXS(Clontech)accordingtomanufacturersprotocolforbloodsamples.PromegaMaxwell16systemwasusedtoextractedDNAfreshfrozentissue.MSK-PCa2normalDNAwasextractedfrom5FFPEtissuecurlsusingPromegaMaxwellFFPEPlusLEVsystem.

Cell159,1–12,September25,2014ª2014ElsevierInc.9

上一页第9页

你可能喜欢

热门文档

相关文档

  • Serum peptidome

    from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...

  • Cryopreservation of mature monocyte-derived human d...

    [6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email